相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)
Anne F. Eder et al.
TRANSFUSION (2007)
Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross
Anne F. Eder et al.
TRANSFUSION (2007)
The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery
Sukhjeewan Basran et al.
ANESTHESIA AND ANALGESIA (2006)
Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency
AE Lovejoy et al.
BLOOD (2006)
Small-dose recombinant activated factor VII (NovoSeven®) in cardiac surgery
S Romagnoli et al.
ANESTHESIA AND ANALGESIA (2006)
Transfusion in coronary artery bypass grafting is associated with reduced long-term survival
CG Koch et al.
ANNALS OF THORACIC SURGERY (2006)
Recombinant activated factor VII: Treating postoperative hemorrhage in cardiac surgery
CV Bishop et al.
ANNALS OF THORACIC SURGERY (2006)
A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery
K Karkouti et al.
TRANSFUSION (2006)
Coagulation Factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation
O Gödje et al.
THORACIC AND CARDIOVASCULAR SURGEON (2006)
The risk associated with aprotinin in cardiac surgery
DT Mangano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
KA O'Connell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss
C von Heymann et al.
THORACIC AND CARDIOVASCULAR SURGEON (2005)
Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia
BT Yilmaz et al.
PEDIATRIC CARDIOLOGY (2005)
Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study
P Diprose et al.
BRITISH JOURNAL OF ANAESTHESIA (2005)
Recombinant activated factor VII for refractory bleeding after cardiac surgery - A retrospective analysis of safety and efficacy
C von Heymann et al.
CRITICAL CARE MEDICINE (2005)
Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting
G Lindvall et al.
ANNALS OF THORACIC SURGERY (2005)
Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome
RH Habib et al.
CRITICAL CARE MEDICINE (2005)
Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery
P Raivio et al.
ANNALS OF THORACIC SURGERY (2005)
Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure
OV Hein et al.
ARTIFICIAL ORGANS (2005)
Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers
TC Reynolds et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass
RJ DiDomenico et al.
CHEST (2005)
In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution
R Ascione et al.
ANNALS OF THORACIC SURGERY (2005)
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience
S Kleinman et al.
TRANSFUSION (2005)
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and other antiplatelet agents during operative coronary revascularization (Executive summary)
VA Ferraris et al.
ANNALS OF THORACIC SURGERY (2005)
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
EI Kapetanakis et al.
EUROPEAN HEART JOURNAL (2005)
Recombinant activated factor VII for acute intracerebral hemorrhage
SA Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors
MP Busch et al.
TRANSFUSION (2005)
Use of recombinant factor VIIa(Novoseven (R)) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation
C Velik-Salchner et al.
ANESTHESIA AND ANALGESIA (2005)
Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis
K Karkouti et al.
TRANSFUSION (2005)
A practical concept for preoperative management of patients with impaired primary hemostasis
J Koscielny et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2004)
Recombinant activated factor VII in paediatric cardiac surgery
JR Egan et al.
INTENSIVE CARE MEDICINE (2004)
Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII
S Malherbe et al.
ANESTHESIOLOGY (2004)
Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery
MS Avidan et al.
BRITISH JOURNAL OF ANAESTHESIA (2004)
'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective
AD Clark et al.
VOX SANGUINIS (2004)
The independent association of massive blood loss with mortality in cardiac surgery
K Karkouti et al.
TRANSFUSION (2004)
Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation
JD Flynn et al.
ANNALS OF PHARMACOTHERAPY (2004)
Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding
T Vanek et al.
JAPANESE HEART JOURNAL (2004)
Transfusion medicine service policies for recombinant factor VIIa administration
LT Goodnough et al.
TRANSFUSION (2004)
Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting
LQ Chen et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes
BD Spiess et al.
TRANSFUSION (2004)
Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin
DR McIlroy et al.
ANESTHESIA AND ANALGESIA (2004)
A practical concept for preoperative identification of patients with impaired primary hemostasis
J Koscielny et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2004)
Impact of clopidogrel in coronary artery bypass grafting
L Englberger et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery
YM Bilgin et al.
CIRCULATION (2004)
Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study
MK Fung et al.
TRANSFUSION (2004)
Does clopidogrel increase blood loss following coronary artery bypass surgery?
MWA Chu et al.
ANNALS OF THORACIC SURGERY (2004)
Recombinant activated factor VII for the treatment of life-threatening haemorrhage
JW Eikelboom et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven®)
KA Tanaka et al.
ANESTHESIOLOGY (2003)
Analysis and results of the recombinant factor VIIa extended-use registry
M Laffan et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Bloodless medicine: clinical care without allogeneic blood transfusion
LT Goodnough et al.
TRANSFUSION (2003)
Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects
E de Jonge et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2003)
Stroke after cardiac surgery: A risk factor analysis of 16,184 consecutive adult patients
J Bucerius et al.
ANNALS OF THORACIC SURGERY (2003)
Stroke after cardiac surgery: A retrospective analysis of the effect of aprotinin dosing regimens
RJ Frumento et al.
ANNALS OF THORACIC SURGERY (2003)
Transfusion medicine: looking to the future
LT Goodnough et al.
LANCET (2003)
The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients
ZH Meng et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2003)
Recombinant FVIIa in the management of uncontrolled hemorrhage
NM O'Connell et al.
TRANSFUSION (2003)
Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair
G Stratmann et al.
ANNALS OF THORACIC SURGERY (2003)
Palliative open heart surgery in an infant with factor VII deficiency
C Tokunaga et al.
ANNALS OF THORACIC SURGERY (2003)
Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device
EV Potapov et al.
ANNALS OF THORACIC SURGERY (2002)
Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury
I Jeroukhimov et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2002)
Aspirin and mortality from coronary bypass surgery
DT Mangano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII
JD Bui et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2002)
Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery
C von Heymann et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2002)
Effect of blood transfusion on long-term survival after cardiac operation
MC Engoren et al.
ANNALS OF THORACIC SURGERY (2002)
Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery
JP Wallis et al.
TRANSFUSION (2002)
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta
M Kastrup et al.
ANNALS OF THORACIC SURGERY (2002)
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries
MA Schreiber et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2002)
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
RY Dodd et al.
TRANSFUSION (2002)
The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting
RH Hongo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device
M Zietkiewicz et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2002)
Potential role for rFVIIa in transfusion medicine
U Hedner et al.
TRANSFUSION (2002)
The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery
JF Baron et al.
ANESTHESIA AND ANALGESIA (2002)
Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery
SB Chelemer et al.
ANNALS OF THORACIC SURGERY (2002)
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients
M Aldouri
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Effect of clopidogrel on bleeding after coronary artery bypass surgery
S Yende et al.
CRITICAL CARE MEDICINE (2001)
The effect of the transfusion of stored RBCs on intestinal microvascular oxygenation in the rat
J van Bommel et al.
TRANSFUSION (2001)
Warfarin therapy does not increase bleeding in patients undergoing heart transplantation
CD Morris et al.
ANNALS OF THORACIC SURGERY (2001)
Recombinant activated factor VII for adjunctive hemorrhage control in trauma
U Martinowitz et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2001)
Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective, randomized, double-blind, placebo-controlled trial
JM Alvarez et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
HGD Hendriks et al.
ANESTHESIA AND ANALGESIA (2001)
Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications - Results of a double-blinded, randomized study
IL Titlestad et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2001)
Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass
GA Nuttall et al.
ANESTHESIOLOGY (2001)
Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass
D Royston et al.
BRITISH JOURNAL OF ANAESTHESIA (2001)
Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa
S Sheth et al.
HAEMOPHILIA (2001)
Factor XIIIA and clot strength after cardiopulmonary bypass
WL Chandler et al.
BLOOD COAGULATION & FIBRINOLYSIS (2001)
On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery
L Capraro et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2001)
Potential role of NovoSeven® in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage
JD Pickard et al.
BLOOD COAGULATION & FIBRINOLYSIS (2000)
Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin
T Kawasaki et al.
STROKE (2000)
分享论文
